Teniposide - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for teniposide and what is the scope of freedom to operate?
Teniposide
is the generic ingredient in one branded drug marketed by Hq Speclt Pharma and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for teniposide.
Summary for teniposide
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 62 |
| Clinical Trials: | 9 |
| Patent Applications: | 2,422 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for teniposide |
| What excipients (inactive ingredients) are in teniposide? | teniposide excipients list |
| DailyMed Link: | teniposide at DailyMed |
Recent Clinical Trials for teniposide
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cookies for Kids' Cancer | Phase 2 |
| Assisi Foundation | Phase 2 |
| Mingzhi Zhang | Phase 4 |
Medical Subject Heading (MeSH) Categories for teniposide
US Patents and Regulatory Information for teniposide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hq Speclt Pharma | VUMON | teniposide | INJECTABLE;INJECTION | 020119-001 | Jul 14, 1992 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
